RevSpark Media RevSpark Media Gameday Competitor Watch
Research checked Nov 12, 2026 · Regional views added Nov 13, 2026 · Window: Aug–Nov 2026
RevSpark Media · Competitive intelligence · Top 10

The market did not reprice TRT. It repriced the door in.

Across the top 10 competitors, TRT base prices barely moved from August to November. What moved was the cost of starting: cheaper first months, cheaper labs, bigger referral credits. At the same time GLP-1 prices fell hard, peptides opened up on Oct 28, and Hims entered injectable TRT. That combination, stacked on platform-wide cost inflation and Q4 seasonality, is the honest explanation for CPL pressure.

What shifted, and what did not

  • Did not move: TRT sticker prices. Marek held $299 + $450 all window. TRT Nation held $99.99/mo. Henry Meds held $129/mo all-in. PeterMD held its tiers after September. Hone held its $155/mo headline.
  • Did move: Top-of-funnel entry. Hone added a $45 first month. TRT Nation cut new-patient labs from $129 to $69 in November. SynergenX extended free tests through year-end and doubled referral credits to $500 on event days. Maximus cut shorter-plan rates while pushing longer prepaid lock-ins.
  • Moved most: GLP-1. Compounded semaglutide hit a $49 to $60/mo floor in October. Branded orals reset at $149/mo.
  • Opened up: Peptides. The Oct 28 HHS enforcement-discretion policy lets 503A pharmacies make six peptides without federal enforcement action. It is a draft, non-binding, and reversible, and it is not an FDA approval.

Verdict and all figures below are from the Nov 12, 2026 research report. Every offer carries its source site and check date in the competitor cards. Items the research could not verify are marked UNVERIFIED and left as open questions.

Gameday, for scale

430+
Gameday clinics, US and Canada (PRNewswire, Oct 28, 2026)
70,000+
Patient reviews, averaging 4.9 stars (same release)
507
Meta ads running for Hone alone, the heaviest advertiser in this set (Sprites proxy, Oct 5, 2026)
+14%
Meta cost per lead, year over year (Metricool Sept 2026: 628,969 campaigns)

Gameday's third-party price figure is TRT from $199/mo (TRT Index, July 2026). That is a third-party compilation, not a Gameday-published price.

Regional views: who each clinic actually competes with

TRT is a local buy. A Tampa clinic does not compete with a Dallas clinic, so the national list below is now split the way the fleet is built: 52 Gameday client groups covering roughly 94 clinics across 24 states (Monday Client Board, Nov 13, 2026), grouped into seven views. Three state views for the big clusters (Florida, Texas, California), four regional views for the rest. The national telehealth layer — Hims, Hone, Maximus, Marek, TRT Nation, PeterMD, Henry Meds — is the same in every view and stays in the top 10 below; each view notes only where a telehealth brand cannot sell into that region. What changes by view is the in-person competition, verified against each chain's own location finder on Nov 13, 2026.

National view: the shared layer

Every regional view carries the same two shared pieces: the market story (the timeline, the entry-price chart, and the CPL analysis below, which are national) and the telehealth top 10, because a man in any state can buy from Hims or TRT Nation tonight. What the regional views change is the in-person layer: which chains have clinics near ours, what they are offering locally, and where telehealth exclusions thin the field.

How the fleet splits

  • California 7 groups, Florida 6, Texas 5 — the three state views.
  • Midwest 14 (IL 4, OH 3, MI 3, SD 2, MO 1, KS 1), West ex-California 8 (AZ 2, UT 2, CO 2, MT 1, OK 1), Northeast 6 (NJ 2, PA 2, MA 1, CT 1), Southeast ex-Florida 6 (GA, NC, LA, TN, AL, MD, one each).
  • Geography, not Monday's labels: Houston is counted in Texas (Monday tags it Midwest) and the Alabama group in the Southeast (Monday tags it Midwest). Maryland's single group (Owings Mills, pausing per the Nov 13 coaching call) is grouped with the Southeast in the plan's view counts and stays listed until it leaves the board.

The pattern across regions

  • Ageless Men's Health is the only in-person rival in all seven views — 21 states on its locator. It publishes no prices anywhere, so its pressure is presence and free lab pop-ups, not offers.
  • SynergenX is a Texas, Midwest, and Southeast problem (10 states verified), not a Florida, California, or Northeast one.
  • Optimize U is a Southeast and Midwest problem with a Florida beachhead. 4Ever Young is everywhere except California in this verified pass.
  • Telehealth exclusions are regional leverage: Hone cannot sell into PA, NJ, CT, or LA; TRT Nation and Maximus cannot sell into Alabama. Those clinics face a thinner national field.

Clinic footprint: Monday Client Board, Active Clients, pulled Nov 13, 2026 (52 groups, ~94 clinics, 24 states). In-person presence in each view verified against the chains' own location finders, checked Nov 13, 2026. Offers are from the Nov 12, 2026 research; full sourcing sits in each competitor card below. The per-region Meta Ad Library check (who is actually advertising in each market) is still owed from Nov 12 and is not in this build.

Florida

The densest in-person competition in the fleet. All three franchise and chain rivals with published offers are verified in-state, and Florida is the one region where every in-person competitor except SynergenX shows up.

WBAFlorida CorporateOcalaOrlandoSarasota / Englewood / Eau ClaireSouth Tampa

In-person competition here

Locator lists Jacksonville–Mandarin, Jacksonville–Perimeter Park, and Tampa — the Tampa clinic sits in South Tampa's market. Offer: no published prices; free lab pop-ups ran Nov 2, 8, and 14, 2026.

Florida-founded (Boca Raton, 2014). Its center list includes Orlando (Lake Nona and Lake Ivanhoe), Naples, Jupiter, and Doral — the Orlando centers sit directly against Gameday Orlando. Offer: HRT from $50/week + $200 credit through Dec 31, 2026.

The Villages opened around August 2026; Destin runs local offers. Entry is paid: labs + consult $129–$169 by clinic, hormone membership $159–$219/mo. Its November promos run per-clinic, not nationally.

SynergenX

No Florida clinics on its location finder (10 states, checked Nov 13, 2026). The most aggressive offer player in the country is not an in-person factor here.

Telehealth in Florida

  • PeterMD is a Florida company (Vero Beach). Its $79/mo 12-month-prepay TRT is the local telehealth price anchor, not a distant one.
  • No Florida exclusions found for Hone, Maximus, or TRT Nation in the Nov 12 research — the full national telehealth set sells here.
  • Henry Meds' $129/mo all-in TRT applies; its Kyzatrex oral at $179/mo is a national offer (the CA exclusion does not apply here).
Watch: 4Ever Young's Florida density around Orlando, and whether Optimize U expands past The Villages into the Tampa–Sarasota corridor where three Gameday groups sit.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

Texas

SynergenX home turf, and it is not close. Houston-headquartered SynergenX lists Texas clinics across Austin, Dallas–Fort Worth, Houston, San Antonio, and Tyler on its finder, and launched online TRT across Texas on Nov 3, 2026. Texas Gameday clinics face the most aggressive offer player in the set, in person and online, at home.

Dallas–LakewoodFriendswoodGeorgetownHouston–Eldridge / West OaksPlano

In-person competition here

Direct same-city overlaps: Low T Center Plano against Gameday Plano, Low T Center Friendswood against Gameday Friendswood, and a deep Houston bench against Houston–Eldridge / West Oaks. Offers: free T test + consult through Dec 31, $250 referral credit, free B12 through Nov 30, and online TRT $99 first month, then $199/mo (launched Nov 3, Texas). All while in Chapter 11.

Locator lists Austin–Georgetown — the same city as Gameday Georgetown — plus two more Austin clinics, Frisco, Houston (Memorial and Sugar Land), San Antonio, and Bedford. No published prices.

Centers in Houston (Voss, Spring, Kingwood, Katy), Flower Mound, and San Antonio; an Allen opening reported in June 2026 was its 11th planned Texas location. Offer: HRT from $50/week + $200 credit through Dec 31.

Optimize U

No Texas locations found on its 42-clinic list (KY/TN core, plus FL, OH, IN, IL).

Telehealth in Texas

  • The regional telehealth threat is SynergenX itself: its Nov 3 online TRT launch ($99 first month) is Texas-only at launch, Labcorp labs and shipped pre-filled syringes. A Texas patient can now get the local rival by mail.
  • No Texas exclusions for the national telehealth set in the Nov 12 research — Hims, Hone, Maximus, Marek, TRT Nation, and PeterMD all sell here.
Watch: SynergenX's grand-opening calendar in DFW and Houston ($500 referral spikes on event days) and whether the Chapter 11 case changes the Texas footprint. Do not match the $99 first month; it is a bankrupt rival buying share.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

California

The largest group count of any state, and the simplest competitive picture: Ageless plus telehealth. None of the other three in-person rivals has a verified California location.

CA CorporateFullerton & Yorba LindaMoreno ValleyPasadenaPowaySacramentoValencia

In-person competition here

11 locator listings: Carlsbad, Irvine, Los Angeles, Oxnard, Rancho Cucamonga, San Francisco, San Ramon, Santa Barbara, Seal Beach, Temecula. Two pressure points: Rancho Cucamonga (hiring Oct 4, 2026) pushes into the Inland Empire toward Moreno Valley, and Carlsbad — Gameday's own HQ city — is the closest rival clinic to Poway. Offer: no published prices; free lab pop-ups.

SynergenX · Optimize U · 4Ever Young

No California locations found on their location finders and clinic lists, checked Nov 13, 2026. Marked as not verified in California rather than assumed absent forever — recheck on the next pass.

Telehealth in California

  • Henry Meds' Kyzatrex oral TRT ($179/mo) is not available in CA. Its $129/mo all-in injectable/cream/enclomiphene offer is.
  • Otherwise no California exclusions in the Nov 12 research: the full national telehealth set, including Hone's 507 running Meta ads, presses on all seven California groups. In California the auction is the competition.
Watch: Ageless's Inland Empire build-out (Rancho Cucamonga today; the Moreno Valley / Valencia corridor is the exposed flank) and any first California opening from 4Ever Young, which is in every neighboring region.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

Midwest

The biggest view by groups, and the only one besides Florida where all four in-person rivals are verified present — including the next SynergenX grand opening on the calendar.

Illinois · 4 groupsOhio · 3 groupsMichigan · 3 groupsSouth Dakota · 2 groupsMissouri · 1 groupKansas · 1 group

In-person competition here

Finder lists Chicago (Burr Ridge, Hoffman Estates, Westmont), Indianapolis (Greenwood, Carmel), Ohio (Dublin, Gahanna, Mason), and Independence, MO. The Greenwood / Indianapolis grand opening is Nov 14, 2026: free T test, $99 women's panel, $500 referral that day only, free B12.

Chicago–Lincoln Park — the same neighborhood as a Gameday clinic — plus Downers Grove, Mokena, Northbrook, and Schaumburg listed as coming soon; Fishers and Greenwood, IN; Beachwood, OH with Cincinnati coming soon.

Verified in Ohio (Cincinnati–Blue Ash) and Indiana (Columbus, Evansville / Newburgh); its September $99 labs ran in Columbus, IN. Illinois is a claimed expansion direction in the Nov 12 research. Labs + consult $129–$169.

Carmel, IN (Indianapolis) and St. Louis, MO — the St. Louis center publishes semaglutide $375/mo and tirzepatide $490/mo, the only local GLP-1 prices in this view.

Telehealth in the Midwest

  • Maximus excludes Indiana and TRT Nation excludes Missouri — two national offers cannot reach the Indiana and Missouri groups.
  • Michigan, South Dakota, and Kansas groups have no verified in-person rival presence in this research; for them this view is a telehealth-only fight. That is a finding about the top-10 set, not proof no local clinic exists.
Watch: the Nov 14 Greenwood opening (expect the $500 referral spike to move Indianapolis CPL for a few weeks) and Ageless's Schaumburg and Cincinnati openings against the Illinois and Ohio groups.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

Northeast

Two in-person rivals, and the thinnest telehealth pressure in the country: the heaviest Meta advertiser in the set cannot sell into three of these four states.

New Jersey · 2 groupsPennsylvania · 2 groupsMassachusetts · 1 groupConnecticut · 1 group

In-person competition here

NJ: Cherry Hill, Edgewater. PA: King of Prussia, Langhorne, Upper Dublin, West Chester. Plus five New York listings next door. Note the split model: Ageless does not offer telehealth in NJ, but its NJ clinics are in-person, which is the model that matters here. No published prices.

NJ: Edgewater, Livingston, Morristown, Princeton, Spring Lake, Ridgewood. PA: Philadelphia, Newtown, Blue Bell–Whitpain. The Whitpain paid-ad landing page is the source of the national $50/week HRT offer — it was built for this market.

SynergenX · Optimize U

No Northeast locations on their finders, checked Nov 13, 2026.

Telehealth in the Northeast

  • Hone is not available in PA, NJ, or CT (it excludes 14 states + DC). The brand running 507 Meta ads nationally is absent from three of this view's four states.
  • Marek Diagnostics is unavailable in NJ (and NY, RI, HI), blunting the premium telehealth offer in New Jersey.
  • Massachusetts has no verified in-person rival in this set and no Hone exclusion on record — its pressure is the standard national telehealth set.
Watch: 4Ever Young's NJ/PA density is the whole fight here. With Hone absent, Northeast CPL should be structurally lower than Florida or Texas — if it is not, the cause is local, not national.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

Southeast, ex-Florida

Optimize U's home turf and the region where telehealth exclusions bite hardest — Alabama in particular faces a thinner national field than any other Gameday state.

Georgia · 1 groupNorth Carolina · 1 groupLouisiana · 1 groupTennessee · 1 groupAlabama · 1 groupMaryland · 1 group (Owings Mills, pausing)

In-person competition here

Its own sitemap lists 10 Tennessee clinics (Brentwood, Chattanooga ×2, Clarksville, Cleveland, East Nashville, Franklin, Jackson, Knoxville, Memphis) on top of its Kentucky core. Gameday's Tennessee group (Hendersonville) sits inside that footprint. Entry: labs + consult $129–$169; September was its most aggressive month ($99 labs).

Tennessee: Chattanooga, Franklin, Hendersonville (Gallatin), Johnson City, Knoxville, Murfreesboro. North Carolina: Charlotte–Pineville. Same offers as Texas: free test through Dec 31, $250 referral, free B12 through Nov 30.

Georgia: Atlanta–Buckhead, Marietta, Peachtree City against Gameday's Georgia group. Tennessee: six listings including Hendersonville — the same city as the Gameday group there — plus Memphis ×2, Nashville ×2, and Cordova.

Apex, NC on its center list, against Gameday's North Carolina group.

Telehealth in the Southeast

  • Alabama is excluded three times over: TRT Nation excludes AL, Maximus excludes AL, and PeterMD's TRT excludes AL (its only exclusions are AL/ID). The Alabama group faces the thinnest telehealth set in the fleet.
  • Hone excludes Louisiana — the Louisiana group's national pressure drops accordingly.
  • Maryland (Owings Mills) is grouped here per the regional plan; it is pausing per the Nov 13 coaching call and stays listed until it leaves the board.
Watch: Tennessee is a three-way in-person fight (Optimize U, SynergenX, Ageless all list Hendersonville-area clinics) around a single Gameday group. Alabama and Louisiana are the opposite: defend the local position while the national players are locked out.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

West, ex-California

Ageless is the broadest rival here, SynergenX holds Colorado and Oklahoma, and 4Ever Young is present in all three multi-group states. Montana is telehealth-only in this set.

Arizona · 2 groupsUtah · 2 groupsColorado · 2 groupsMontana · 1 groupOklahoma · 1 group

In-person competition here

Arizona: 9 listings across the Phoenix metro and Tucson. Colorado: Denver–Cherry Creek, Denver–Tech Center, Westminster. Utah: Draper, Farmington, Orem, Riverton, St. George, Weber — six Utah clinics against two Gameday Utah groups.

Colorado: Colorado Springs, Greenwood Village, Westminster. Oklahoma: Edmond, Tulsa. Its Westminster, CO clinic and Ageless's Westminster clinic sit on the same street (Pecos St) — the Denver suburbs are contested by both.

Arizona: Mesa, Gilbert, Scottsdale. Colorado: Arvada, Colorado Springs, Fort Collins. Utah: Cottonwood Heights. Offer: HRT from $50/week + $200 credit through Dec 31.

Optimize U

No locations in these states on its 42-clinic list.

Telehealth in the West

  • No exclusions among AZ, UT, CO, MT, or OK for Maximus or TRT Nation in the Nov 12 research — the full national telehealth set applies, on top of the in-person pressure in AZ, UT, and CO.
  • Montana: no verified in-person rival presence in this research. As far as the top-10 set goes, the Montana group's competition is telehealth-only.
Watch: Ageless's Utah build-out (six clinics, including St. George and Weber) against two Gameday Utah groups, and the Ageless–SynergenX overlap in Denver's suburbs, which tends to pull local offers sharper.

Presence verified against each chain's location finder, Nov 13, 2026. Offers: Nov 12, 2026 research, full profiles below.

What it costs to start, November 2026

The escalation is at the front door. These are entry and first-step prices verified in November 2026, each with its catch attached. They are not comparable monthly treatment prices, and the notes under the chart say why.

Entry price by competitor (USD)

Lowest published way in, November 2026. Read the catches before quoting any of these numbers in a planning meeting.

$0 $50 $100 $150 Entry price, USD. Full catches in the notes below. Hone $45 Hims from $49/mo TRT Nation $69 PeterMD $79/mo SynergenX online $99 first mo Henry Meds* $129/mo all-in
  • Hone $45: first month of Premium only, struck through from $155 on buy.honehealth.com (read Nov 12, 2026). Then $155/mo, medications separate from $28/mo. Realistic all-in is roughly $183 to $215+/mo.
  • Hims from $49/mo: treatment price on hims.com/testosterone (read Nov 12, 2026), plus a $49 membership fee at checkout. Tier prices of $79/$159/$179 per month are single-sourced to one review site and UNVERIFIED.
  • TRT Nation $69: the November TRT Starter Plan lab panel for new patients only, cut from $129. Treatment itself stays $99.99/mo (trtnation.com, read Nov 12, 2026).
  • PeterMD $79/mo: only on a 12-month prepay, $948 upfront. Month-to-month is $139/mo, labs extra (getpetermd.com, read Nov 12, 2026).
  • SynergenX $99: first month of the online TRT service launched Nov 3, 2026 across Texas, then $199/mo (BusinessWire, Nov 3, 2026).
  • *Henry Meds is the first alternate, not top 10. It is in the chart because $129/mo all-in (labs, meds, supplies, shipping included) is the cleanest comparison price in the market (henrymeds.com, read Nov 12, 2026).

Market timeline, August to November 2026

The moves that changed the auction and the offer landscape, in order. Amber marks the dates that most directly hit Gameday clinics.

  1. Jul 2–3, 2026 · Pre-window setup
    SynergenX files Chapter 11, then launches “$250 for 250”

    Chapter 11 filed Jul 2 (S.D. Texas, Case No. 26-90644). The referral-credit push launched the next day. A top-10 competitor has been escalating offers while operating as debtor-in-possession ever since.

  2. Aug 2026
    Meta removes placement and device exclusion at ad set level

    Less targeting control for every health advertiser, from this point in the window onward.

  3. Aug–Sep 2026
    Henry Meds drops injectable tirzepatide

    Oral only since. Lilly litigation is reshaping GLP-1 offers from the side.

  4. Sep 22, 2026
    Hone partners with BODYBAR Pilates

    20% off testing and a free Premium year one for roughly 21,000 members across 40+ studios. Telehealth buying offline distribution.

  5. Sep 24–26, 2026
    SynergenX San Antonio grand opening: $500 referral spike

    Referral value doubled from the standing $250 for the relocation and grand-opening days.

  6. Oct 1, 2026
    SynergenX adds a free B12 shot for new patients

    Sweetener added to the free-test funnel. Runs to Nov 30, 2026.

  7. Oct 18, 2026
    Mochi Health cuts compounded semaglutide to $60/mo

    Tirzepatide to $90/mo (USA Today, Oct 18, 2026). The GLP-1 price floor drops again. REMEVi followed on Nov 11 at $96/mo semaglutide and $168/mo tirzepatide.

  8. Oct 21, 2026
    Hims launches injectable and oral TRT

    Billed as Hims' largest men's-health launch to date. The biggest DTC brand in the category is now a direct TRT bidder in the same auctions as local clinics.

  9. Oct 28–30, 2026
    HHS opens six peptides to compounding; Gameday answers the same day

    Enforcement discretion for BPC-157, TB-500, KPV, MOTS-c, epitalon, and semax (Federal Register, Oct 30, draft and reversible). Gameday issued its safety-standard release the same day, Oct 28.

  10. Nov 2, 2026
    Hims runs “The Tune Up” with Calvin Johnson

    A mass-testing funnel built on “know your score,” not a price offer.

  11. Nov 3, 2026
    SynergenX launches online TRT across Texas

    $99 first month, then $199/mo. Labcorp labs, virtual consult, pre-filled syringes shipped home. An in-person chain moves into telehealth.

  12. Nov 6, 2026
    Hims signs the Lilly deal

    Zepbound and Foundayo at Lilly self-pay prices. Branded GLP-1 consolidation continues.

  13. Nov 9, 2026
    Hims reports Q3 and announces Peptides+

    Revenue $890.4M, up 49% year over year; gross margin 57%, down from 74%. Peptides+ (sermorelin, glutathione, NAD+, B12) launches late November, no prices disclosed. US weight-loss marketing was deliberately moderated in Q3, with a ramp planned for Q1 2027.

  14. Nov 10–11, 2026
    Five more states join the FTC suit against Hims

    The original FTC, Utah, and LA County suit over subscription and cancellation practices was filed Jul 29, 2026. Legal pressure grows in the same week as the Peptides+ waitlist goes live.

  15. Nov 2026
    TRT Nation launches the $69 TRT Starter Plan

    New-patient lab panel cut from $129 to $69. The sharpest top-of-funnel move in the window, from the market's price-floor provider. Base TRT price did not move: still $99.99/mo.

Does any of this explain CPL jumps?

Yes, in part. Offer shifts are one layer on top of platform inflation and seasonality. No single cause explains it, and the layers stack. Anyone giving one reason is wrong.

1

Platform-wide Meta inflation

Meta's own figures show the average price per ad rose 12% year over year in Q2 2026, with impressions up 14%. Metricool's September 2026 report (628,969 campaigns, $471M spend) found Meta cost per lead up 14% year over year. Every advertiser in every category pays more.

2

Q4 seasonality

Healthcare Meta CPL runs roughly $42 to $52 through the year (SuperAds and AdAmigo 2026 benchmarks) and spikes toward $70 in Q4, then drops sharply in January. A November jump is partly the calendar.

3

More bidders for the same men

The Meta-addressable TRT audience is roughly 42 million US men (Meta audience data, cited by Holistic SEO). National telehealth brands each spend in the single-digit to mid-seven-figure range per month on Meta, $5M+/mo each by one agency's estimate. Hone alone runs 507 ads and launched 108 new ads in one week in early October. Hims entered injectable TRT on Oct 21 with a mass-testing funnel. More bidders with bigger budgets in a fixed audience pushes CPM and CPL up for everyone, including local clinics.

4

Sharper offers convert better, and the auction charges everyone else

Free tests, $45 first months, $69 lab panels, and $500 referral credits convert cold traffic at higher rates. When a competitor's offer converts better, Meta's auction rewards them with cheaper delivery and charges everyone else more to reach the same people. The top-of-funnel escalation in this report feeds this directly.

5

A new category added bidders in the same quarter

The Oct 28 peptide policy opened a category that was previously gray-market. Every competitor with a peptide line can now advertise it openly, hitting the same male health audience in Q4.

6

Less targeting control

Meta removed placement, platform, and device exclusion at ad set level in August 2026 and expanded personal-attributes policy enforcement in 2026. Health advertisers have fewer levers to avoid expensive or low-quality inventory.

Benchmarks for context (all third-party, 2026)

$42–$52 healthcare Meta CPL, spiking toward $70 in Q4SuperAds / AdAmigo 2026
$52.98 health and fitness CPLWordStream, via 2026 benchmark roundups
$21.80 health and wellness CPMTriple Whale, 40,000+ ad accounts
$120–$400 cost per booked TRT consultation, higher in saturated metrosHolistic SEO, TRT-specific agency data
$25–$80 med spa Meta CPL rangeSparkUGC 2026

The top 10

Selected from three inputs, not memory: the Men's Health Atlas 2026 rankings (updated Nov 10 to 12, 2026), FDD-based franchise footprint data (wellnessfranchisehq.com, Nov 7, 2026), and telehealth market presence (subscriber counts, rankings, ad visibility). One adjustment: Low T Center and SynergenX are the same company mid-rebrand, so they are merged and PeterMD was promoted to keep ten distinct companies. Open a card for the full offer history, ad evidence, sources, and what is still unverified. This top 10 is the shared national layer: the telehealth profiles apply in every regional view above; the in-person profiles (Ageless, SynergenX, Optimize U, 4Ever Young) apply only in the views where the regional panels verify them.

Showing all 10 competitors.

In-person chain · Corporate-ownedDirection: steady

Footprint: clinic count is genuinely murky. Its homepage says 65+, landing pages say 75+, third parties count 80+, and a June 2026 opening video says 94 clinics across 21 states. No single figure is confirmed. Why top 10: largest in-person men's health chain after Gameday; Atlas in-person TRT ranking #3. Founded 2007. Weekly in-clinic TRT injections, weight loss, skin care. Telehealth available except NJ and MS.

Current offer · Nov 2026
No published prices anywhere

The offer is “Make an Appointment,” plus free lab draws run as local pop-up events at gyms, chiropractors, and salons: Nov 2, 8, and 14, 2026. Insurance accepted (copay + deductible). A self-pay rate exists but the amount is unpublished.

Offer history, ad evidence, sources

Aug–Nov 2026

  • No price or national offer shift: nothing published to move. The offer stayed appointment-led with free labs all window.
  • Free-lab pop-ups every month: Aug 24 (Ankeny); Sep 4, 22, 24; Oct 22; Nov 2, 8, 14.
  • Growth is by new clinics and pop-ups, not offer escalation. Schaumburg, IL and Cincinnati “coming soon”; Rancho Cucamonga hiring Oct 4, 2026.

Ad and social evidence

Runs Meta lead ads: an indexed landing URL shows campaign “OCT26 - Leads_TRT_InstagramVideo4” with geo ad sets (try.agelessmenshealth.com, UTM parameters read Nov 12, 2026).

Name trap, verified

Try Ageless (tryageless.com) and AgelessRx are separate companies. Both are excluded from this profile.

UNVERIFIED: any Ageless price at all. Exact clinic count (65 vs 75 vs 80+ vs 94). Any guarantee or refund terms. Meta Ad Library contents: direct read returned HTTP 403 on Nov 12, 2026.

Sources: agelessmenshealth.com and try.agelessmenshealth.com landing pages (checked Nov 12, 2026) · menshealthatlas.com/compare/best-in-person-trt-clinics/ (updated Nov 10, 2026) · dated Facebook event posts for free lab draws, Aug–Nov 2026.

Hybrid chain + telehealth · incl. Low T Center & HerKareDirection: more aggressive

Footprint: ~64 clinics across 10–11 states (company figure, July 2026), Texas-heavy; about 40–47 are Low T Center clinics. 500,000+ patients claimed. Bills insurance, HSA/FSA accepted. Chapter 11: filed Jul 2, 2026 (S.D. Texas, Case No. 26-90644, confirmed from Stretto court filings), operating as debtor-in-possession. By clinic count they are far smaller than Gameday (64 vs 430+), despite their self-claimed “largest hybrid provider” line.

Current offers · verified live Nov 12, 2026
Free T test + free consult, through Dec 31

Women's full hormone panel $99 (marked down from a $299 eval) through Dec 31. $250 referral credit, standing. Free B12 shot for new patients, Oct 1 to Nov 30. Self-inject treatment from $105/mo. Online TRT launched Nov 3 across Texas: $99 first month, then $199/mo.

Offer history, ad evidence, sources

Aug–Nov 2026

  • Jul 3: “$250 for 250” initiative launched (BusinessWire). Jul 11: Tyler, TX grand opening with free T test and $99 women's eval.
  • August: no dated company offer or announcement found. Gap stated, not filled.
  • Sep 24–26: Southwest San Antonio relocation and grand opening with a $500 referral spike, 2x the standing $250.
  • Oct 1: free B12 shot promo launched. Nov 3: online TRT launched across Texas, a direct move into the telehealth space they positioned against in September.
  • Nov 14 (scheduled): Greenwood / Indianapolis grand opening repeats the playbook: free T test, $99 women's panel, $500 referral that day only, free B12.
  • Escalating despite bankruptcy: free-test offer extended through year-end, referral value doubled on event days, B12 sweetener added, rebrand rolling throughout. No core TRT price cuts found.

Ad and social evidence

Low T Center runs geo-targeted Google CPC (indexed landing URLs with Google UTM parameters). No dated SynergenX Instagram or Facebook offer posts surfaced in search.

UNVERIFIED: current clinic count (64 is from July; closures during bankruptcy unknown). The $82.3M debt figure (secondary source only). Whether July “$250 for 250” credits were actually paid in November. What the headline “as low as $59/mo” includes: the $105/mo self-inject figure is what September verification supports, so $59 is not a comparable price. August 2026 offers. Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: synergenxhealth.com/patient-resources/special-offers/, /free-testosterone-test/, /full-hormone-test/, /greenwood-grand-opening/ (checked Nov 12, 2026) · BusinessWire Jul 3, Jul 14, Sep 24, Nov 3, 2026 · cases.stretto.com, Case No. 26-90644 · lowtcenter.com (checked Nov 12, 2026).

Franchise · In-personDirection: steady, no national shift

Footprint: 38–42 clinics (the company says both “38+” and “42”); 13 states claimed. Kentucky/Tennessee core, expanding into Florida, Ohio, Indiana, Illinois. ~50,000 patients claimed. The Villages, FL opened around August 2026. Founded 2016, franchising since Sept 2020.

Current offers · Nov 2026
Labs + consult $129–$169, per clinic

No national pricing published. Hormone membership $159–$219/mo (medications, labs, and recovery services included, 3-month commitment). November promos are local only: Bowling Green veterans $99 labs plus a free t-shirt; women joining get a recovery guest pass; first recovery session free.

Offer history, ad evidence, sources

Aug–Nov 2026

  • Most aggressive moment was September: $99 labs (Columbus, IN all month; London, KY $50 off).
  • October–November reverted to audience-specific promos (first responders $75 off, veterans) and community events.
  • No new service lines, guarantees, or rebrand in the window.

Ad and social evidence

One Meta campaign confirmed indirectly: Optimize U Destin's aesthetics offer page carries Facebook campaign UTMs from agency “Staplerz.”

UNVERIFIED: exact clinic count (38 vs 42) and full state list (the sitemap only rendered KY/TN). Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: optimizeucenters.com (checked Nov 12, 2026) · wellnessfranchisehq.com/guides/optimize-u-franchise-cost · lakeandsumterstyle.com, The Villages opening (Aug 2026).

Franchise · Anti-aging & wellnessDirection: promotional rotation

Footprint: 75 units across 22 states (Franchise Herald, Nov 5, 2026). Closed 2025 at 68 locations and $55M system sales, up 27.8%. Average 2025 gross revenue $1,020,756 across 49 franchised centers open 12+ months (median $862,165); top location $3.54M (2026 FDD figures via franchise reporting).

Current offers · Nov 2026
HRT from $50/week + $200 credit

From $50/week on a live paid-ad landing page (read Nov 12, 2026), free consultation, labs billed separately. $200 credit toward a wellness membership or peptide package (minimum 3-month commitment), valid through Dec 31, 2026. No national weight-loss price; the St. Louis location publishes semaglutide $375/mo and tirzepatide $490/mo. November is holiday cadence: Pre-Holiday Sale Nov 3, Black Friday member early access Nov 9–26, Botox Day Nov 18.

Offer history, ad evidence, sources

Aug–Nov 2026

  • Aug–Sep: summer IV and filler bundles, ending Sep 30.
  • October: membership acquisition plus the first-ever peptide and wellness credit in the headline promo. Peptides entered the headline offer in October.
  • November: holiday member-early-access cadence. No base price reductions found.

Ad and social evidence

Paid-ad landing pages live at ads.get4everyoung.com (read Nov 12, 2026).

UNVERIFIED: national weight-loss and peptide pricing (not published at brand level). The TRT intro of $99/mo for the first 3 months plus a $149 intro lab panel was last seen September 2026 and is UNVERIFIED for November. Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: ads.get4everyoung.com/whitpain-hrt-50-female (read Nov 12, 2026) · 4everyoungstl.com/treatments/weight-loss · wellnessfranchisehq.com (published Nov 7, 2026) · Franchise Herald, Nov 5, 2026 · sharpsheets.io franchise cost analysis.

Telehealth · Public (NYSE: HIMS)Direction: aggressive category expansion

Scale: Q3 2026 revenue $890.4M, up 49% year over year; 2.788M subscribers (up 13% YoY but down 100,000 sequentially); $105/mo revenue per subscriber; net loss $33M; gross margin compressed to 57% from 74% (reported Nov 9, 2026). FY2026 guidance tightened to $3.13–$3.15B. Testosterone is not available in all 50 states and no public state list exists.

Current offers · Nov 2026
Injectable TRT live since Oct 21

Compounded twice-weekly subcutaneous injection, generic testosterone cypionate weekly IM, and FDA-approved oral Kyzatrex. On hims.com/testosterone (read Nov 12, 2026): $49 membership fee at checkout, treatment from $49/mo, 2 labs per year included, no insurance, no FSA/HSA. Weight loss is brand-name only: Wegovy Pill from $149/mo, Zepbound $299, Foundayo $149, plus a mandatory $149/mo membership ($39 first month), so all-in is roughly $298–$600/mo. Peptides+ launches late November (sermorelin, glutathione, NAD+, B12), no prices disclosed.

Offer history, ad evidence, sources

Aug–Nov 2026

  • Jul 29: FTC, Utah, and LA County sued over subscription and cancellation practices. Five more states joined Nov 10–11.
  • Oct 21: injectable + oral TRT launch, billed as its largest men's-health launch to date.
  • Nov 2: “The Tune Up” event with Calvin Johnson. Nov 6: Lilly deal signed (Zepbound and Foundayo at Lilly self-pay prices). Nov 9: Q3 results plus Peptides+ announcement.
  • US weight-loss marketing was deliberately moderated in Q3, with a marketing ramp planned for Q1 2027. The theme is mass testing as the funnel, not price offers.
  • Live overhang: DEA telemedicine flexibilities for controlled substances expire Dec 31, 2026. That expiry directly affects the TRT rollout.

Ad and social evidence

A third-party Aug 25 to Sep 2 sweep found 19 Meta ads, eligibility and “Why Hims?” angles.

UNVERIFIED: injectable and oral TRT tier prices ($79/$159/$179 per month are single-sourced to one Oct 23 review site). Enclomiphene current price ($99/mo prepay through Oct 17 vs $49/mo on Oct 23: repricing or different variant, unresolved). Peptides+ pricing. Testosterone state list. Compounded semaglutide at $199/mo is still cited by competitor sites but absent from Hims' brand-only catalog: likely stale. Scope of the expanded FTC suit could not be reconciled across reports. Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: investors.hims.com releases, Oct 21 and Nov 9, 2026 · hims.com/testosterone and hims.com/weight-loss (read Nov 12, 2026) · Lilly deal reporting (Nov 2026).

Telehealth · LongevityDirection: flat prices, heavier discounting

Scale: claims 300,000+ patients tested and 65,000+ treated (March 2026 investor memo). Not available in 14 states + DC; partial availability in 7 more. Why top 10: top-rated telehealth TRT across third-party rankings, and the heaviest Meta advertiser in this set.

Current offers · verified live Nov 12, 2026
Premium TRT $45 first month, then $155/mo

First month struck through from $155 on Hone's own buy page. Includes a 50+ biomarker test at Quest, physician video consult, quarterly retesting. Medications billed separately (testosterone injections from $28/mo), so realistic all-in is roughly $183–$215+/mo. Basic $25/mo; Plus $135/mo. Weight loss: no semaglutide or tirzepatide at all, only compounded liraglutide at $160/mo.

Offer history, ad evidence, sources

Aug–Nov 2026

  • Headline prices flat all four months. Two real moves: sermorelin raised $130 to $175/mo in September (+35%), and the steep $45 first-month discount appearing by November, the first intro-price promo seen in the window (launch date unknown).
  • Sep 22: BODYBAR Pilates partnership: 20% off testing plus a free Premium year one for ~21,000 members, 40+ studios.
  • Expansion, not price: Lp(a) heart testing added; perimenopause push in October. Women's hormone creative now outpaces testosterone creative.

Ad and social evidence

507 ads in Meta Ad Library, all running (Sprites proxy read, Oct 5, 2026): 86% image, 14% video, and 108 new ads launched in one week in early October. First-time national TV advertiser in H1 2026, $2.11M spend.

UNVERIFIED: the $45 first-month offer's launch date (live Nov 12, absent from all Aug–Oct reviews). Revenue and headcount conflict across sources. Plus tier status still “in transition.” Meta ad spend (only an unverified agency estimate exists). Direct Meta Ad Library read was not possible; Hone is covered via the Sprites proxy only.

Sources: buy.honehealth.com/mens-opt/membership/ (read Nov 12, 2026) · honehealth.com/mens/testosterone-replacement-therapy/ · sprites.ai/hone-health-ads (Oct 5, 2026) · menshealthatlas.com (Hone ranked #3, injectable TRT).

Telehealth · Performance medicineDirection: most aggressive repricing

Scale: Financial Times #7 on the Americas' Fastest Growing Companies 2026. $20M raised total. Claims profitability and 8-figure ARR, doubling year over year. No patient count published. TRT in 47 of 51 jurisdictions. Open FDA warning letter, Jun 8, 2026 (MARCS-CMS 730095), over compounded GLP-1 claims; no closeout posted as of Nov 12, 2026.

Current offers · verified Nov 11, 2026
Headline $99.99/mo, on prepay only

The $99.99 headline holds only on 9-month (enclomiphene) / 10-month (injectable) prepaid plans: $899.91 / $999.90 upfront, cannot be ended early. Month-to-month: $179.99 (enclomiphene/cream), $199.99 (injectable), $249.99 (oral T). Medications included; labs extra ($99.99 starter kit). King Protocol roughly $199.99/mo with a money-back guarantee if testosterone does not increase. GLP-1: brand-name orforglipron $199.99/mo; tirzepatide $99.99/mo on a 12-month plan. No compounded semaglutide (dropped October).

Offer history, ad evidence, sources

Aug–Nov 2026

  • October GLP-1 overhaul: dropped compounded semaglutide entirely, dropped month-to-month GLP-1, cut tirzepatide roughly 50–58% (12-month $240.66 to $99.99/mo), added brand-name orforglipron at $199.99/mo.
  • November TRT restructure: 12-month plan became 9-month; 6-month injectable became 10-month; month-to-month enclomiphene cut $199.99 to $179.99; 3-month cut $149.99 to $119.99/mo.
  • Pattern: cheaper sticker prices funded by longer lock-ins, plus a post-FDA-letter pivot from compounded semaglutide to tirzepatide and brand-name orals.

Ad and social evidence

Paid Meta and Reddit run in-house (a Director of Paid Media plus an open specialist role). No dated organic Instagram or Facebook posts found for Aug–Nov; that is a gap, not evidence of absence.

UNVERIFIED: patient count (not published anywhere found). November first-month promos: the October $49.99 limited-time offer and “50% off first month” may not survive the Nov 11 restructure. GLP-1 state list. Maximus's own site lists brand-name tirzepatide at both $449.99 and $1,249.99/mo (unresolved). No Ad Library counts retrievable; direct read was not possible.

Sources: maximustribe.com (direct read Nov 11, 2026) · GlobeNewswire, Apr 3, 2026 (FT ranking) · FDA warning letter MARCS-CMS 730095 (Jun 8, 2026) · medswitcher.com (Maximus ranked #1) · menshealthatlas.com/providers/maximus/.

Telehealth · Premium, diagnostics-ledDirection: flat prices, creator-led

Scale: claims all 50 states for the program; third parties say 45–47. Diagnostics explicitly unavailable in NY, NJ, RI, HI. Why top 10: premium segment leader and the price ceiling of this market.

Current offers · verified Nov 12, 2026
$749 before any medication

$299 one-time Guided Optimization intake + $450 minimum lab panel. Ongoing treatment “averages $80–$200/month.” No subscription. Medication prices are not published anywhere; TRT, peptide, and GLP-1 monthly costs are third-party estimates only ($225–$275/mo for TRT). Diagnostics: Total Health Panel Comprehensive (80+ biomarkers) $495; range $150–$1,950. No free labs, consult, or first-month offer. Only standing 10% creator codes.

Offer history, ad evidence, sources

Aug–Nov 2026

  • None on price. The $299 + $450 structure was identical at every dated checkpoint from Aug 19 through Nov 12.
  • Only escalation was promotional: late-October “Win Your Year” sweepstakes (2 x $3,500 credit, entries closed Nov 8) pushed by large fitness creators, plus a Black Friday / Cyber Monday paid-social campaign for Diagnostics, confirmed via UTM parameters only.

Ad and social evidence

Appears in Sprites.ai's Oct 5, 2026 Ad Library read with a longest-running ad of 301 days.

UNVERIFIED: medication prices (unpublished by design). Patient counts, revenue, growth (nothing public). HQ and founding year conflict across sources. Black Friday Diagnostics offer details (campaign confirmed via UTMs only). “Win Your Year” winners (no announcement found by Nov 12). Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: marekhealth.com/faq (read Nov 12, 2026) · marekdiagnostics.com lab bundles and Total Health Panel Comprehensive · sprites.ai/healthcare-ads (Oct 5, 2026) · menshealthatlas.com (Marek ranked #4, injectable TRT).

Telehealth · BudgetDirection: flat base, sharper funnel

Scale: roughly 44–45 states (exact count conflicts across sources: 44 vs 45 vs 47). Marketing is SEO, blog content, and review volume: 4.9 stars, 2,075 Google reviews shown on-site. No patient count, revenue, or growth figures public. Why top 10: the price floor of telehealth TRT, and the sharpest November top-of-funnel move in the window.

Current offers · verified Nov 12, 2026
TRT $99.99/mo + $69 starter labs

TRT $99.99/mo (2.5-month minimum, roughly $250 first charge). TRT + HCG $180/mo. Enclomiphene $99.99/mo. Labs $129, but the November $69 TRT Starter Plan cuts the full lab panel to $69 for new patients only. Includes medications, supplies, shipping, unlimited consults. No membership, no contract, no refunds. Weight loss: tirzepatide only, $219/mo any dose, compounded with B12 (page updated Oct 27, 2026).

Offer history, ad evidence, sources

Aug–Nov 2026

  • Base prices never moved all window. TRT held at $99.99/mo throughout.
  • September: weekend sale START25, 25% off first order ($75/mo TRT), expired Sep 7, on their own page.
  • October: a first-month promo existed (confirmed Oct 12); its value was not recorded. Gap.
  • November: $69 TRT Starter Plan launch. Promotional intensity stepped up twice while the base price stayed flat.

Ad and social evidence

Not in Sprites' 83-brand Ad Library list, which is not proof it runs no ads. No dated TRT Nation Instagram or Facebook offer post found for Aug–Nov; a live check of its social pages would fill this.

UNVERIFIED: current peptide and ED prices (only April 2026 figures exist; stale). October first-month promo value. Whether $219 tirzepatide requires a 3-month plan. A claimed 12% military discount is contradicted by another source. Exact state count. Aggregator codes (20% codes, “$50 off storewide”) are user-reported, not company offers. Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: trtnation.com/testosterone-replacement-therapy/, /new-patient-lab-orders/, /weekend-sale-is-live/, GLP-1 page updated Oct 27, 2026 (all read Nov 12, 2026) · menshealthatlas.com/providers/trt-nation/ · NY Post online TRT roundup, Oct 2026.

Telehealth · TRT-ledDirection: flat prices, reputation repair

Scale: claims “over 400,000 patients served” (verified live Nov 12, 2026; already present in August). Self-reported only, no independent verification found. Based in Vero Beach, FL. TRT state exclusions narrowed from 12 states (July/August) to AL/ID only by Sep 21, 2026, or the 12-state list was GLP-1-specific all along; unresolved.

Current offers · verified live Nov 12, 2026
TRT from $79/mo, 12-month prepay

Tiers from the main TRT page: $79/mo on 12-month prepay ($948 upfront), $109/mo on 6-month, $139/mo month-to-month. Labs extra ($95 panel; $340 first year), so first-year all-in is roughly $1,288. Free virtual consultation. 20%-off price-match guarantee live on-page. Weight loss: semaglutide $270/mo flat or $149/mo prepaid; tirzepatide $249/mo billed quarterly (still $249 on Nov 11). Peptides: sermorelin $585 per 3 months, NAD+ $369 per 8–10 weeks. Homepage now leads with longevity and biomarker testing (133+ biomarkers, biological age).

Offer history, ad evidence, sources

Aug–Nov 2026

  • Price ladder flat after September. August shows conflicting readings ($119/mo on Aug 6 vs $139 tiers Aug 26–31) across PeterMD's own pages and funnels: likely funnel inconsistency, not provably a repricing. PeterMD's own pages still disagree with each other on price, labs, and states.
  • Aug 10, 2026: BBB rating went from F to A+ accredited, a reputational reset.
  • Trustpilot removed PeterMD's profile (13,900+ reviews) for guideline violations, yet the site still displays “4.9/5, based on 20k+ reviews” today.

Ad and social evidence

Known Meta advertiser in general terms (its CGO bio cites paid-media campaigns), but no specific current creative could be verified. No verified official Instagram or Facebook handles, follower counts, or dated social posts found for Aug–Nov 2026.

UNVERIFIED: the 400K patient figure (self-reported). Founding year (sources conflict: 2014 vs 2016 vs 2019 vs 2021). Month-to-month semaglutide rate, ED/hair/bundle pricing, veterans offer (last checked Jul–Sep). Enclomiphene price conflicts across sources. Meta Ad Library contents (HTTP 403, Nov 12, 2026).

Sources: getpetermd.com/, /begin-trt/, /about-us/ (read Nov 12, 2026) · AccessNewswire PeterMD pricing explainer · glp1newstoday.com PeterMD review · NY Post online TRT roundup (“Best Quick Online TRT Clinic”).

No competitor matches that filter and search. Clear the search or pick another model.

What Gameday needs to do to stay competitive

The research report's eight calls, in its own order. The through-line: do not fight telehealth on price. Fight on the things a mailed kit and a video call cannot do.

1

Do not chase the telehealth price floor

TRT Nation at $99.99/mo, PeterMD at $79/mo, Hims from $49/mo, and compounded semaglutide at $49–$60/mo are prices an in-person clinic with real estate, staff, and same-day labs cannot match and should not try to match. That race is funded by venture capital, prepaid lock-ins, and compounded products under legal pressure. Gameday wins on what telehealth cannot do.

2

Lean into the in-person advantage, explicitly

Same-day labs with results in 20 minutes, walk-in availability, a clinician in the room, and the lounge experience are the differentiators. Telehealth offers a kit in the mail and a video call. Every Gameday offer should name the in-person difference rather than competing on monthly price.

3

The free test is no longer differentiating on its own

SynergenX runs free testosterone tests through year-end. Ageless runs free lab pop-ups monthly. The test gets them in the door, but the follow-through is where Gameday wins or loses: speed to consult, booking, showing up. Sell the speed and certainty of the next step, not just the free test.

4

Move fast on peptides while the window is open

The Oct 28 policy opened the category. Hims Peptides+ launches late November. 4Ever Young already has a peptide credit in its headline promo. Gameday's Oct 28 safety-standard positioning is the right frame: legitimacy and medical supervision against gray-market sellers. Peptides are the growth line where the in-person, clinician-led model is a genuine edge.

5

Do not chase the GLP-1 floor; bundle instead

Compounded semaglutide at $49–$60/mo is unwinnable and legally fraught: compounding now requires documented medical necessity per prescription, not a blanket shortage exemption. Gameday's weight-loss offer should be the bundled in-person program (labs, coaching, TRT plus weight loss together, medical supervision), priced and sold as a different product from a $49 mailed vial.

6

Watch Hims' Q1 2027 marketing ramp

Hims deliberately moderated US weight-loss marketing in Q3 2026 and plans a ramp in Q1 2027, with injectable TRT and Peptides+ both live by then. Expect a step-up in Meta competition in January from the largest advertiser in the category.

7

Watch the Dec 31 DEA expiry

If the telemedicine flexibilities for controlled substances are not extended, telehealth TRT prescribing gets materially harder and in-person clinics benefit directly. If they are extended, the status quo holds. Either way, Gameday should be ready to say plainly that its model does not depend on a telemedicine rule.

8

Watch SynergenX in Texas and Indiana

A bankrupt competitor escalating offers (free tests, $500 referral spikes, $99 first-month online TRT) can distort local CPL and set price expectations Gameday does not want to match. Track their grand-opening calendar; Greenwood, Indianapolis is Nov 14.

First alternate and also watched

Not top 10, but close enough to matter. Brief notes only; no deep dive was run on the “also watched” group.

Henry Meds · First alternate

Telehealth, weight-loss-led. TRT $129/mo all-in (injections, cream, or enclomiphene, including labs, supplies, shipping), verified live Nov 12, 2026. Kyzatrex oral TRT $179/mo. Prices essentially flat Aug 5 to Nov 12; injectable tirzepatide dropped between July and August (oral only since), plausibly Lilly-litigation-driven; Lilly's April 2025 false-advertising suit is active. A “up to $150 off for new patients” weight-loss promo likely launched mid-to-late October. No peptides at all. Patient count and state list UNVERIFIED. henrymeds.com.

Talon Wellness

Hybrid telehealth + in-person, $65/mo, all 50 states. Atlas in-person #1 by score, but a small footprint.

Joi + Blokes

Telehealth TRT, $99/mo, 34 states. Atlas injectable #5.

Male Excel

Telehealth TRT, $142/mo, 39 states. Atlas injectable #6.

Ulo

Telehealth TRT, $159/mo injections. NY Post “Best TRT Clinic Overall.”

Rex MD

Telehealth, $250/mo, all 50 states. Atlas injectable #12. Introductory offer $49 for new patients (April 2026 figure).

Vault Health · Fountain TRT

Telehealth men's health brands named among the leading DTC providers (Dataintelo; Rex MD 2026 roundup). Fountain is urologist-led.

BodyLogicMD · Forum Health · Limitless Male

In-person: BodyLogicMD in 12 states, Forum Health in 15, Limitless Male (oral only) in 9. No published prices for BodyLogicMD or Forum Health.

NuHealth Wellness · Revive Men's Health

NuHealth: hybrid, $45/mo, 4 states (Atlas in-person #5). Revive: in-person chain; footprint not verified in this research.

Gaps, open questions, and the next checks

What this page cannot tell you yet, stated plainly. Nothing in the gaps below was filled in with a guess.

  • Meta Ad Library could not be read for any competitor. Every direct attempt returned HTTP 403 on Nov 12, 2026. Active ad creative, hooks, spend, and start dates are UNVERIFIED across the board. Partial proxy data exists for Hone (Sprites.ai, Oct 5: 507 ads) and Marek (Sprites.ai: longest-running ad 301 days) only. A live-browser check of the Ad Library for each brand is the fix.
  • Dated social posts are sparse for SynergenX, TRT Nation, Maximus, Henry Meds, and PeterMD for Aug–Nov 2026. A live check of their Instagram and Facebook pages would fill this.
  • The most material per-competitor unknowns: Ageless has no published price at all; SynergenX's current clinic count and debt figure; Hims' TRT tier prices and state list; Marek's medication prices; PeterMD's 400K patient claim; Henry Meds' patient count and state list.
  • Regional ad activity is still unchecked. The regional views verify in-person presence from location finders (Nov 13, 2026), but who is actually advertising in each market needs the per-region Meta Ad Library check that returned HTTP 403 on Nov 12. Presence is not the same as ad pressure.
  • Offers in this market move monthly. A re-check in early December is warranted. The RevSpark research sheet (Instagram outliers, Meta Ad Library long-runners, competitors) also still needs cross-checking against this page once it can be read.
Nov 13, 2026Public comment closes on the HHS peptide policy
Nov 14, 2026SynergenX Greenwood / Indianapolis grand opening, $500 referral that day only
Late Nov 2026Hims Peptides+ launches, pricing still undisclosed
Dec 31, 2026DEA telemedicine flexibilities expire; SynergenX free-test and $99 eval offers expire
Feb 2027Advisory committee reviews five more peptides, incl. GHK-Cu and Melanotan II